FLUOPTICS Part of Getinge

📍 Grenoble, France🗓 Founded 2009👥 28 employees💰 Last funded Jul 2013
Biotechnology Research🌐 fluoptics.com
Website LinkedIn
Fluoptics is a young and innovative company in the field of fluorescence imaging for both clinical and preclinical applications. In clinics, Fluoptics develops solutions to optically guide cancer surgery. This approach is based on an intra-operative near infra-red fluorescence detector and fluorescent probes which specifically target tumors. This technology, extensively tested on animals, drastically improves cancer surgery in providing surgeons with an acute delineation of cancerous nodules during the surgery. Fluoptics develops and markets the Fluobeam, a unique fluorescence imaging system with an open design and an excellent sensitivity in the near infra-red spectrum. The company also proposes near infra-red molecular probes AngioStampTM for tumors and angiogenesis, and SentiDyeTM for vascular networks and lymphatic drainage. The instrument, as well as the probes, helps in understanding disease mechanisms and in developing new therapies.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in FLUOPTICS Part of Getinge?
FLUOPTICS Part of Getinge has 1 investors on record on gritt.io, 1 mid-stage.
When did FLUOPTICS Part of Getinge last raise funding?
The most recent investment in FLUOPTICS Part of Getinge recorded on gritt.io was in July 2013.
When was FLUOPTICS Part of Getinge founded?
FLUOPTICS Part of Getinge was founded in 2009.
What industry is FLUOPTICS Part of Getinge in?
FLUOPTICS Part of Getinge operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is FLUOPTICS Part of Getinge based?
FLUOPTICS Part of Getinge is headquartered in Grenoble, France.